So in the case of lenders, my reckoning is AI will help them do more with less expenditure on head count, allow them to provide better services, better credit underwriting at lower expenditure and I think therefore, for lenders in our country, it is a positive.
Explore Now
NEW DELHI: Smallcap- and multicap-oriented PMS (portfolio management service) funds, an investment tool of rich investors, outperformed in April and delivered up to 14 per cent returns to clients.
Top guns of the PMS industry also delivered handsome returns for the month. Domestic equity benchmark Sensex fell 1.5 per cent for the month, while Nifty shed 0.4 per cent.
Kotak AMC Pharma Fund finished as the top performer of the month, returning 13.39 per cent, according to data provided by PMSBazaar.
Sun Pharma, Dr Reddy’s Labs, Cipla,
Cadila Healthcare and Aurobindo Pharma were the top five holdings in its portfolio.
Sectoral bets, especially metals, pharma and IT, have been proving to be beneficial for fund managers in the past couple of months, as the Covid-19 pandemic intensified and commodity prices rose.
The ‘cult’ of Marcellus propels it to the top of India’s PMS league
SECTIONS
Share
ETMarkets.com
Related
MUMBAI: As Nifty50 tanked 24 per cent in March 2020 amid a raging pandemic, Marcellus Investment Managers’ own funds fell about 15 per cent. At that time, the asset manager’s founder and chief investment officer Saurabh Mukherjea would have felt relieved, and perhaps a hint of pride, at his fund’s resilience.
The relative outperformance of Marcellus Investment Managers during the worst selloff in Indian equity market since the Global Financial Crisis eventually became the catalyst for a blowout year for the PMS.
While you continue to like the Kotaks and the
Berger Paints of the world, are you looking at expanding the number of stocks in your portfolio?
Two things are playing out. One, flows into Marcellus have been very strong over the last 12 months. As the money that we are managing is basically moving towards the billion dollar mark, we are adding a few more stocks because there is only so much you can buy in a name and many of the names that we own we are already accounting for a substantial part of the free float and that is a little uncomfortable.
PMS biggies flop again; small, midcap strategies steal the show
SECTIONS
Share
Synopsis
Data compiled by PMS Bazaar showed Rising Start Opportunity strategy of Valentis Advisors, which invests in up and coming smallcap and midcap stocks, emerged the top performer with a 9.08 per cent return.
Getty Images
INSIGHTS
NSE
Explore Now
NEW DELHI: PMS schemes focused on smallcaps and midcaps stole the show in January, as some big names from the industry failed to outperform their respective benchmarks thanks to a sell-off in stocks at the end of the month, which hit their returns.
Data compiled by PMS Bazaar showed Rising Start Opportunity strategy of Valentis Advisors, which invests in up and coming smallcap and midcap stocks, emerged the top performer with a 9.08 per cent return.